Crucell: Investors

Home | Contact | Search | Site Map

About Us

	Corporate Profile
	Share Information
	Financial Information
	Press Releases
	Event Calendar
	Presentations
	Shareholder Services
	Investor Relations Contact
	Crucell's press releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader. If you are new to RSS, we suggest you read the Introduction to RSS article.

Dutch German

2008 \| 2007 \| 2006 \| 2005 \| 2004 \| 2003 \| 2002 \| 2001 \| 2000

14 Nov 2001	Galapagos Genomics and Pharmacia enter Three Year Gene Target Identification Collaboration
22 Oct 2001	Galapagos Genomics and Procter & Gamble Pharmaceuticals Announce Functional Genomics Collaboration
22 Oct 2001	Crucell Announces 3rd Quarter 2001 Results
05 Oct 2001	Professor Ada Kruisbeek To Lead Crucell's Antibody Research
28 Sep 2001	Crucell Appoints Director of Business Development for its Biotherapeutics Production Platform
20 Sep 2001	Crucell Appoints Dr Jaap Goudsmit As Senior Vice President Vaccine Research
30 Aug 2001	Galapagos Genomics and VIB Announce Functional Genomics Collaboration in Alzheimer's Disease
29 Aug 2001	Crucell Appoints VP Corporate Development & Strategy
23 Aug 2001	Crucell announces the issuance of a major patent in the field of Phage Antibodies
22 Aug 2001	Galapagos Genomics and Vertex Pharmaceuticals in Gene Function Collaboration
16 Aug 2001	Crucell will be holding a Conference Call regarding the Centocor Agreement
16 Aug 2001	Crucell enters development and commercialization agreement with Centocor for human antibodies against cancer
24 Jul 2001	Crucell announces 2nd Quarter 2001 Results
11 Jul 2001	Crucell Presents Advact(TM), a New Improved Vaccine
28 Jun 2001	Crucell and Vaxin to jointly develop new type of vaccines which make injections obsolete
26 Jun 2001	Crucell signs PER.C6 license and production agreement with Selective Genetics
13 Jun 2001	Galapagos Genomics and Bayer Announce Functional Genomics Collaboration in Asthma Research
01 Jun 2001	Crucell presents Advac , a new improved vaccine technology
23 May 2001	Crucell boosts its target discovery and antibody development engine
15 May 2001	Crucell and University Medical Center Utrecht cooperate on Antibody and Vaccine treatment for Type 2 Diabetes
08 May 2001	Crucell announces First Quarter Results
26 Apr 2001	Crucell Q1 conference call invitation
10 Apr 2001	Crucell Appoints Executive Director of Business Development for its Antibody Business
03 Apr 2001	Crucell's PER.C6 Cell-Line Used In Merck's HIV-1 Vaccines Research Program
12 Mar 2001	Crucell's Revenues in 2000 Increase 116%
31 Jan 2001	Crucell Signs Production Agreement with DirectGene
15 Jan 2001	Crucell Signs Licensing Deal With Cell Genesys for PER.C6 Packaging Cell Technology
11 Jan 2001	Crucell Appoints Executive Director of Intellectual Property